Navigation Links
Biopure Announces 2007 Third Quarter Financial Results
Date:8/23/2007

uarterly report on Form 10-Q filed on June 14, 2007, which can be accessed in the EDGAR database at the U.S. Securities and Exchange Commission's (SEC) website, http://www.sec.gov. The company undertakes no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof. A full discussion of the company's operations and financial condition can be found in the company's filings with the SEC.

The content of this release does not necessarily reflect the position or the policy of the U.S. Government or the Department of Defense, and no official endorsement should be inferred.

Contact: Todd Wood Herb Lanzet (Investors)

Biopure Corporation H.L. Lanzet Inc.

(617) 234-6576 (212) 888-4570

IR@biopure.com lanzet@aol.com

BIOPURE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

Three Months Ended Nine Months Ended

July 31 July 31

2007 2006 2007 2006

Total revenues $550 $396 $1,763 $1,284

Cost of revenues 3,089 2,939 9,026 9,351

Gross loss (2,539) (2,543) (7,263) (8,067)

Operating expenses:

Research and

development 1,618 1,772 5,397 5,112

Sales and marketing 341 197 1,099 524

General and

administrative 2,107 2,239 6,365 6,826

Total operating

expenses 4,06
'/>"/>

SOURCE Biopure Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)...  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today ... company at the following conferences. , Deutsche Bank ... May 29, 2013 , Presentation time: 12:00 p.m. P.T. ... , Presentation date: Wednesday June 5, 2013 , Presentation ... A live webcast and 30-day archive of these presentations will ...
(Date:5/22/2013)...  Grifols, a global healthcare company based in ... study demonstrating that a higher dose of PROLASTIN © ... the alpha 1 protein in patients with alpha ... within the normal range for healthy individuals. AAT deficiency ... of the alpha 1 proteinase inhibitor (A1PI) protein ...
(Date:5/22/2013)... LAKE CITY , May 22, 2013 /PRNewswire/ ... ) today announced it received 510(k) clearance from ... Varian,s diagnostic X-ray image processing workstation that combines ... on one platform.  Varian,s Nexus DRF Digital X-Ray ... a variety of image receptors, including CCD cameras ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2
... designed for more uniform drug ... ... Boston,Scientific Corporation (NYSE: BSX ) today announced comprehensive data ... historically controlled trials, which evaluate,the TAXUS(R) Liberte(R) Paclitaxel-Eluting Stent System in ...
... with Kogenate FS Reduces the,Risk of Joint Damage ... Damage, BERKELEY, Calif., Oct. 10 Bayer ... Drug Administration (FDA) has,approved routine prophylaxis with Kogenate(R) ... bleeding episodes and the risk of,joint damage in ...
Cached Medicine Technology:Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5
(Date:5/22/2013)... 22, 2013 Mari’s Skin Care, a peaceful ... the first in the state of Texas to offer a ... Medical and Esthetic Tissue Activation, also known as collagen ... years in Europe, but has just recently made its way ... skin from inside out by building collagen and elastin. ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The ... (Amino Resins, Melamine Formaldehyde, Melamine Urea Formaldehyde), Applications ... - Global Trends and Forecasts to 2018" defines ... forecasting of the global volume and revenue. ... for the Global Amino Resins Market with analysis ...
(Date:5/21/2013)... May 22, 2013 Spring is the ... nutrition--from farmers' markets filled with whole foods to weather ... most of the season the nutrition experts at Brilliant ... not to miss. , 1. Eating Locally, With the ... shoppers to linger and explore, spring is a great ...
(Date:5/21/2013)... May 21, 2013 Heritage Woods of ... BMA affordable assisted living community, is hosting a Quality Home ... at 2 p.m. on Tuesday, May 28. , The community, ... serves older adults of all incomes, including those on Medicaid, ... Arthritis program is open to the public. There is ...
(Date:5/21/2013)... Standard advice for mattress shoppers often consists ... given industry’s less than exceptional satisfaction ratings and the ... Consumer Mattress Reports sets out to revise this advice ... .” , This article addresses several components of the ... not be readily apparent to many shoppers. From prices ...
Breaking Medicine News(10 mins):Health News:Mari's to Offer New Treatment from Europe 2Health News:Asia-Pacific Leads in Consumption of Urea Formaldehyde Resins Followed by Europe and North America - New Report by MarketsandMarkets 2Health News:Asia-Pacific Leads in Consumption of Urea Formaldehyde Resins Followed by Europe and North America - New Report by MarketsandMarkets 3Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis 2Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2
... News) -- Adding more weight to concerns about possible ... people who take the drugs, known as bisphosphonates, may be ... (femur). Osteoporosis is a bone-thinning disease that is ... unusual type of break that often occurs spontaneously, without any ...
... team of researchers, including a scientist from the Viral ... a type of herpesvirus infection of the eye is ... that causes blindness in the elderly. The scientists ... the production of vascular endothelial growth factor, or VEGF, ...
... 2012) Behavioral support from peers and primary care office ... as much as starting a new drug, a new study ... Medicine San Antonio, is the senior author. The randomized, ... support from peers and primary care office staff could ...
... (HealthDay News) -- Men with severe gum disease, known as ... new study that finds young men and the elderly at ... a large study to identify almost 33,000 men with ... condition. Of these study participants, about 12 percent ...
... quality of care you receive be affected by how your ... at Brigham and Women,s Hospital (BWH), doctors who dictated their ... who used structured documentation. The study is published ... Association . The researchers evaluated 18,569 visits by 7,000 ...
... Spanish . Flexible sigmoidoscopy, a screening ... fewer side effects than colonoscopy, is effective in reducing the ... according to research sponsored by the National Cancer Institute, part ... that spanned almost 20 years, researchers found that overall colorectal ...
Cached Medicine News:Health News:More Research Points to Long-Term Ills With Bone Drugs 2Health News:Type of viral infection of eye associated with disease causing blindness in the elderly 2Health News:Behavioral support from peers, staff lowers patients' blood pressure 2Health News:Behavioral support from peers, staff lowers patients' blood pressure 3Health News:Severe Gum Disease, Impotence May Be Linked 2Health News:To dictate or not to dictate? 2Health News:NIH study finds sigmoidoscopy reduces colorectal cancer rates 2Health News:NIH study finds sigmoidoscopy reduces colorectal cancer rates 3Health News:NIH study finds sigmoidoscopy reduces colorectal cancer rates 4
Stainless steel lancet blade in stainless steel....
Sharp diamond shaped double blade in stainless steel....
... CT MIYABI system is a ... CT scanner on rails (Sliding ... angiography unit. Both systems use ... which can be switched between ...
AXIOM Multistar is a ceiling-mounted single plane C-Arm system for universal angiography, diagnostics and intervention...
Medicine Products: